The Network of Hematopoietic Cytokines
暂无分享,去创建一个
[1] S. de Vos,et al. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product. , 1993, Cancer research.
[2] T. Hirano,et al. Production of interleukin 6 and its relation to the macrophage differentiation of mouse myeloid leukemia cells (M1) treated with differentiation-inducing factor and 1 alpha,25-dihydroxyvitamin D3. , 1989, Biochemical and biophysical research communications.
[3] O. Ottmann,et al. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. , 1988, Journal of immunology.
[4] J. Lotem,et al. Induction of genes for transcription factors by normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells. , 1990, Leukemia.
[5] L. Sachs,et al. FORMATION OF PURE SUSPENSIONS OF MAST CELLS IN TISSUE CULTURE BY DIFFERENTIATION OF LYMPHOID CELLS FROM THE MOUSE THYMUS. , 1963, Journal of the National Cancer Institute.
[6] L. Sachs. The molecular control of blood cell development. , 1987, Science.
[7] I. Kawashima,et al. Interleukin-11: a novel stroma-derived cytokine. , 1992, Progress in growth factor research.
[8] L. Sachs. Growth, differentiation and the reversal of malignancy. , 1986, Scientific American.
[9] R. Kamen,et al. The human hematopoietic colony-stimulating factors. , 1987, Science.
[10] J. Lotem,et al. Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[11] W. Paul,et al. Hematopoietin sub-family classification based on size, gene organization and sequence homology , 1993, Current Biology.
[12] C. Peschle,et al. Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level. , 1991, Blood.
[13] L. Sachs,et al. The continued requirement for inducer for the development of macrophage and granulocyte colonies , 1968, Journal of cellular physiology.
[14] F. Ruscetti,et al. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. , 1988, Blood.
[15] J. Ihle,et al. Procedures for the purification of interleukin 3 to homogeneity. , 1982, Journal of immunology.
[16] J. Lipton,et al. Separation of different molecular forms of macrophage‐ and granulocyte‐inducing proteins for normal and leukemic myeloid cells , 1980, International journal of cancer.
[17] J. Bazan. Neuropoietic cytokines in the hematopoietic fold , 1991, Neuron.
[18] J. Lotem,et al. The network of hemopoietic regulatory proteins in myeloid cell differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[19] J. Lotem,et al. Indirect induction of differentiation of normal and leukemic myeloid cells by recombinant interleukin 1. , 1989, Leukemia research.
[20] S. Akira,et al. Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.
[21] J. Lotem,et al. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. , 1992, Blood.
[22] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[23] J. B. Blacklock,et al. Cytokine Responses to Intraventricular Injection of Interleukin 2 into Patients with Leptomeningeal Carcinomatosis: Rapid Induction of Tumor Necrosis Factor α, Interleukin 1β, Interleukin 6, γ-Interferon, and Soluble Interleukin 2 Receptor (Mr 55,000 Protein) , 1992 .
[24] J. Lotem,et al. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells. , 1990, Blood.
[25] T. Rose,et al. Oncostatin M is a differentiation factor for myeloid leukemia cells. , 1992, Journal of immunology.
[26] N. Shen,et al. Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells , 1992, Journal of cellular biochemistry.
[27] D. Metcalf,et al. The growth of mouse bone marrow cells in vitro. , 1966, The Australian journal of experimental biology and medical science.
[28] L. Sachs,et al. The cloning of normal "mast" cells in tissue culture. , 1965, Journal of cellular physiology.
[29] H. Asaoku,et al. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. , 1989, Blood.
[30] K. Onozaki,et al. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. , 1989, Journal of immunology.
[31] S. Jacobsen,et al. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. , 1991, Blood.
[32] J. Hatzfeld,et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.
[33] K. Takeda,et al. Identity of differentiation inducing factor and tumour necrosis factor , 1986, Nature.
[34] J. Lotem,et al. Role of different normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells , 1988, International journal of cancer.
[35] L. Sachs,et al. The induction of clones of normal mast cells by a substance from conditioned medium. , 1966, Experimental cell research.
[36] J. Lotem,et al. Rescue from programmed cell death in leukemic and normal myeloid cells. , 1991, Blood.
[37] U. Gullberg,et al. Characterization of a relationship between the T‐lymphocyte derived differentiation inducing factor (DIF) and lymphotoxin: A common receptor system for DIF, lymphotoxin and tumor necrosis factor downregulated by phorbol diesters , 1987, European journal of haematology.
[38] J. Abrams,et al. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor , 1992, The Journal of experimental medicine.
[39] J. Lotem,et al. Coupling of growth and differentiation in normal myeloid precursors and the breakdown of this coupling in leukemia , 1983, International journal of cancer.
[40] J. Bonner,et al. Differentiation , 1968, Nature.
[41] A. Ganser,et al. In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. , 1991, European cytokine network.
[42] K. Ohta,et al. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. , 1993, Cancer research.
[43] L. Sachs,et al. Feedback inhibition of the development of macrophage and granulocyte colonies. I. Inhibition by macrophage. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Goeddel,et al. Genomic cloning and heterologous expression of human differentiation-stimulating factor. , 1989, DNA.
[45] A. Kelso,et al. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). , 1987, The EMBO journal.
[46] G. Yancopoulos,et al. Ciliary neurotrophic factor and its receptor complex. , 1992, Progress in growth factor research.
[47] J. Lotem,et al. Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells , 1989, Molecular and cellular biology.
[48] J. Lotem,et al. Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Kishimoto,et al. Cytokine receptors and signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] T. Hirano,et al. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta. , 1988, Journal of immunology.
[51] A. Kimchi,et al. Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation , 1986, Cell.
[52] J. Lotem,et al. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3. , 1988, Blood.
[53] J. Lotem,et al. Regulation of cell‐surface receptors for hematopoietic differentiation‐inducing protein MGI‐2 on normal and leukemic myeloid cells , 1987, International journal of cancer.
[54] A. Miyajima,et al. Common subunits of cytokine receptors and the functional redundancy of cytokines. , 1992, Trends in biochemical sciences.
[55] L. Sachs,et al. Characterization of the inducer required for the development of macrophage and granulocyte colonies. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[56] D. Metcalf. Granulocyte-macrophage colony-stimulating factors , 1985, Cell.
[57] J. Lotem,et al. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells. , 1989, Blood.